Earnings History Data for Theravance Biopharma, Inc. (TBPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Theravance Biopharma, Inc.

Theravance Biopharma, Inc. is a biopharmaceutical company. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including bacterial infections, central nervous system (CNS)/pain, respiratory disease, and gastrointestinal (GI) motility dysfunction. Theravance Biopharma, Inc. is based in George Town, Cayman Islands.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	AH		TBPH	Theravance Biopharma, Inc.	437.36	-0.26	-0.24	-0.17	Theravance Biopharma GAAP EPS of -$0.26 misses by $0.03, revenue of $16.87M beats by $1.45M [11/12/2024 4:41 PM]	9.70	0.79 (8.87%)	9.30	0.39 (4.38%)	7.44 - 11.71	236,026	180,000	1,365
Theravance Biopharma GAAP EPS of -$0.26 misses by $0.03, revenue of $16.87M beats by $1.45M [11/12/2024 4:41 PM] Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value [2024-11-12 04:05PM] What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings [Nov-11-24 07:16AM]
05-08-2024	AH		TBPH	Theravance Biopharma, Inc.	487.79	-0.34	-0.22	-0.28	Theravance Biopharma GAAP EPS of -$0.34 misses by $0.13, revenue of $54.5M beats by $39.19M [8/5/2024 4:11 PM]	7.84	-1.75 (-18.25%)	8.98	-0.61 (-6.36%)	7.69 - 11.71	1,836,980	290,000	46,940
Theravance Biopharma GAAP EPS of -$0.34 misses by $0.13, revenue of $14.25M [8/5/2024 4:11 PM]
13-05-2024	AH		TBPH	Theravance Biopharma, Inc.	456.12	-0.24	-0.28	-0.32	Theravance Biopharma GAAP EPS of -$0.24 beats by $0.01, revenue of $14.51M beats by $0.56M [5/13/2024 4:19 PM]	9.40	-0.18 (-1.88%)	9.68	0.10 (1.04%)	8.21 - 11.71	241,337	520,000	601
Theravance Biopharma GAAP EPS of -$0.24 beats by $0.01, revenue of $14.51M beats by $0.56M [5/13/2024 4:19 PM]
26-02-2024	AH		TBPH	Theravance Biopharma, Inc.	432.00	-0.17	-0.15	-0.21	Theravance Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $17.6M beats by $0.03M [2/26/2024 4:13 PM]	9.66	0.43 (4.66%)	9.23	0.0 (0.00%)	8.21 - 12.03	468,172	320,000	6,614
Theravance Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $17.6M beats by $0.03M [2/26/2024 4:13 PM]
07-11-2023	AH		TBPH	Theravance Biopharma, Inc.	520.21	-0.17	-0.21	-0.21	Theravance Biopharma GAAP EPS of -$0.17, revenue of $15.7M [11/7/2023 4:51 PM]	10.23	0.50 (5.14%)	9.73	0.0 (0.00%)	8.25 - 12.03	847,440	340,000	63,260
Theravance Biopharma GAAP EPS of -$0.17, revenue of $15.7M [11/7/2023 4:51 PM]
07-08-2023	AH		TBPH	Theravance Biopharma, Inc.	573.35	-0.28	-0.22	-0.04	Theravance Biopharma GAAP EPS of -$0.28 misses by $0.07, revenue of $13.75M misses by $1.67M [8/7/2023 4:15 PM]	9.75	-0.08 (-0.81%)	9.83	0.0 (0.00%)	8.69 - 12.03	519,184	300,000	6,438
Theravance Biopharma GAAP EPS of -$0.28 misses by $0.07, revenue of $13.75M misses by $1.67M [8/7/2023 4:15 PM]
08-05-2023	AH	4:05 PM ET (May 8)	TBPH	Theravance Biopharma, Inc.	710.66	-0.32	-0.27	-0.24	Theravance Biopharma GAAP EPS of -$0.35 misses by $0.10, revenue of $10.4M misses by $3.3M [5/8/2023 4:25 PM]	11.36	0.03 (0.26%)	11.42	0.09 (0.79%)	7.53 - 12.03	570,955	470,000	403
Theravance Biopharma GAAP EPS of -$0.35 misses by $0.10, revenue of $10.4M misses by $3.3M [5/8/2023 4:25 PM]
27-02-2023	AH	4:05 PM ET (Feb 27)	TBPH	Theravance Biopharma, Inc.	682.42	-0.21	-0.20	-0.43	Theravance Biopharma Q4 results mixed, co to reduce headcount by about 17% [2/27/2023 4:24 PM]	10.84	0.28 (2.60%)	10.56	0.0 (0.00%)	7.53 - 11.83	497,438	500,000	7,046
Theravance large shareholder demands strategic review, cost cutting [2/27/2023 11:26 AM] Theravance Biopharma Q4 results mixed, co to reduce headcount by about 17% [2/27/2023 4:24 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	TBPH	Theravance Biopharma, Inc.	663.15	-0.21	-0.20	-0.48		10.35	0.30 (2.99%)	10.39	0.34 (3.38%)	7.53 - 13.17	1,610,842	590,000	5,234

04-08-2022	AH	4:05 PM ET (Aug 4)	TBPH	Theravance Biopharma, Inc.	737.56	-0.04	-0.06	-0.80	Theravance Biopharma GAAP EPS of -$0.11, revenue of $11.1M [8/4/2022 4:42 PM]	8.74	-0.74 (-7.81%)	8.74	0.0 (0.00%)	6.10 - 14.28	1,172,112	650,000	1,111
Theravance Biopharma GAAP EPS of -$0.11, revenue of $11.1M [8/4/2022 4:42 PM] Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-04-22 04:05PM]
05-05-2022	AH	4:05 PM ET (May 5)	TBPH	Theravance Biopharma, Inc.	773.44	-0.24	-0.14	-1.24	Theravance Biopharma GAAP EPS of -$0.34 misses by $0.23, revenue of $13.2M misses by $1.28M [5/5/2022 4:34 PM]	9.32	-0.41 (-4.21%)	9.32	0.0 (0.00%)	6.10 - 20.00	954,085	620,000	20,362
Theravance Biopharma GAAP EPS of -$0.34 misses by $0.23, revenue of $13.2M misses by $1.28M [5/5/2022 4:34 PM] NICE Investigate Helps British Transport Police Streamline Management of Digital Evidence and Investigations to Keep UK Railways Safe from Crime [May-04-22 06:30AM] Theravance Biopharma, Inc. Reports First Quarter 2022 Financial Results and Provides Business Update [May-05-22 04:05PM] Theravance Biopharma (TBPH) Reports Q1 Loss, Lags Revenue Estimates [May-05-22 07:15PM] Theravance's (TBPH) Q1 Earnings and Sales Miss Estimates [May-06-22 04:15PM]
23-02-2022	AH	4:05 PM ET (Feb 23)	TBPH	Theravance Biopharma, Inc.	708.24	-0.43	-0.30	-0.92	Theravance Biopharma GAAP EPS of -$0.43 misses by $0.12, revenue of $14.95M beats by $1.39M [2/23/2022 5:12 PM]	9.58	0.47 (5.16%)	8.67	-0.44 (-4.83%)	0.0 - 0.0	769,475	0	42,016
Theravance Biopharma GAAP EPS of -$0.43 misses by $0.12, revenue of $14.95M beats by $1.39M [2/23/2022 5:12 PM] Drug/Biotech Stocks' Q4 Earnings on Feb 23: BMRN, BHC & More [Feb-22-22 12:01PM] Theravance Biopharma to Participate in an Upcoming Investor Conference [Feb-22-22 06:00AM] Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Feb-23-22 04:05PM] Theravance Biopharma (TBPH) Reports Q4 Loss, Lags Revenue Estimates [Feb-23-22 06:05PM] Theravance's (TBPH) Q4 Earnings and Sales Miss Estimates [Feb-24-22 05:40PM]
03-11-2021	AH	4:00 PM ET (Nov 3)	TBPH	Theravance Biopharma, Inc.	589.97	-0.48	-0.60	-1.16	Theravance Biopharma EPS beats by $0.08, misses on revenue [11/3/2021 4:17 PM]	8.50	0.42 (5.20%)	8.50	0.0 (0.00%)	6.10 - 22.74	1,170,602	420,000	26,932
Theravance Biopharma EPS beats by $0.08, misses on revenue [11/3/2021 4:17 PM] Theravance Biopharma, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-03-21 04:05PM] Theravance Biopharma (TBPH) Reports Q3 Loss, Lags Revenue Estimates [Nov-03-21 05:55PM] Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript [Nov-04-21 05:31AM] Theravance's (TBPH) Q3 Earnings Beat, Restructuring On Track [Nov-04-21 09:39AM]
03-08-2021	AH	4:05 PM ET (Aug 3)	TBPH	Theravance Biopharma, Inc.	934.29	-0.80	-0.96	1.00	Theravance Biopharma reports Q2 results [8/3/2021 4:33 PM]	13.00	-0.63 (-4.62%)	13.00	0.0 (0.00%)	12.72 - 22.74	782,939	280,000	9,149
Theravance Biopharma reports Q2 results [8/3/2021 4:33 PM] 3 Strong Buy Stocks Trading at Steep Discounts [Aug-02-21 10:26AM] Theravance Biopharma, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-03-21 04:00PM] Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates [Aug-03-21 05:25PM] Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript [Aug-04-21 10:01AM] Theravance's (TBPH) Q2 Earnings Beat, Pipeline On Track [Aug-04-21 09:44AM]
04-05-2021	AH	4:05 PM ET (May 4)	TBPH	Theravance Biopharma, Inc.	1,380	-1.24	-1.05	-1.14	Theravance Biopharma EPS misses by $0.16, misses on revenue [5/4/2021 4:13 PM]	19.57	-0.31 (-1.56%)	19.57	0.0 (0.00%)	14.48 - 29.81	171,892	240,000	1,321
Theravance Biopharma EPS misses by $0.16, misses on revenue [5/4/2021 4:13 PM] Theravance Biopharma, Inc. to Host Earnings Call [May-04-21 03:15PM] Theravance Biopharma, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update [May-04-21 04:05PM] Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates [May-04-21 05:20PM] Theravance Biopharma Inc (TBPH) Q1 2021 Earnings Call Transcript [May-05-21 12:01AM] Theravance (TBPH) Q1 Earnings Lag Estimates, Pipeline on Track [May-05-21 10:45AM]
23-02-2021	AH	4:05 PM ET (Feb 23)	TBPH	Theravance Biopharma, Inc.	1,200	-0.92	-1.04	-1.17	Theravance Biopharma EPS beats by $0.10, misses on revenue [2/23/2021 4:16 PM]	17.62	-0.03 (-0.17%)	19.00	1.35 (7.65%)	14.48 - 31.35	1,023,820	347,373	2,289
Theravance Biopharma EPS beats by $0.10, misses on revenue [2/23/2021 4:16 PM] Theravance Biopharma Inc (TBPH) Q4 2020 Earnings Call Transcript [Feb-24-21 06:32AM]
05-11-2020	AH	4:35 PM ET (Nov 5)	TBPH	Theravance Biopharma, Inc.	1,200	-1.16	-0.98	-1.05	Theravance Biopharma EPS misses by $0.15, misses on revenue [11/5/2020 4:39 PM]	16.80	-2.68 (-13.73%)	19.48	0.0 (0.00%)	14.48 - 31.54	868,132	423,799	2,986

06-08-2020	AH	4:05 PM ET (Aug 6)	TBPH	Theravance Biopharma, Inc.	1,260	-1.00	-0.95	-0.72	Theravance Biopharma EPS beats by $0.04, misses on revenue [8/6/2020 4:44 PM]	19.01	-1.83 (-8.78%)	15.83	-5.01 (-24.03%)	15.72 - 31.54	399,779	261,919	759

06-05-2020	AH		TBPH	Theravance Biopharma, Inc.	1,680	-1.14	-1.06	-1.32		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0